Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1992 Feb;60(2):565–570. doi: 10.1128/iai.60.2.565-570.1992

Molecular chimerization of Pasteurella haemolytica leukotoxin to interleukin-2: effects on cytokine and antigen function.

H P Hughes 1, M Campos 1, A A Potter 1, L A Babiuk 1
PMCID: PMC257665  PMID: 1730490

Abstract

A chimeric recombinant protein composed of the lktA gene product from Pasteurella haemolytica fused to bovine interleukin-2 (IL-2) was made. The LKT-IL-2 chimera was compared with recombinant bovine IL-2 with regard to the ability to induce proliferative responses and LAK cell activity in bovine peripheral blood mononuclear cells in vitro. In both instances, chimerization had no effect on IL-2 activity. Similarly, the LKT component was unaffected in its ability to induce an effective immune response after immunization. The adjuvant properties of IL-2 have been established in a number of models, and this effect was tested by using the chimera. A multiple-injection protocol of LKT-IL-2 was compared with single-dose administration of LKT. The results obtained indicate that while there was no increase in specific antibody production, the IL-2 component of the chimera may be able to affect antigen-specific proliferation, as assessed by limiting-dilution analysis. Use of cytokine-antigen chimeras may provide a valuable antigen-adjuvant formulation that is simple to produce and purify and thus have economic advantages over conventional preparations. Furthermore, chimerization will also ensure that the adjuvant acts at the same site as the antigen, thus optimizing immunostimulatory activity.

Full text

PDF
565

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baker P. E. Bovine interleukin 2: cloning, high level expression, and purification. Vet Immunol Immunopathol. 1987 Dec;17(1-4):193–209. doi: 10.1016/0165-2427(87)90140-1. [DOI] [PubMed] [Google Scholar]
  2. Campos M., Rossi C. R. Cytotoxicity of bovine lymphocytes after treatment with lymphokines. Am J Vet Res. 1986 Jul;47(7):1524–1528. [PubMed] [Google Scholar]
  3. Chengappa M. M., McLaughlin B. G., Kadel W. L., Maddux R. L., Greer S. C. Efficacy of a live Pasteurella multocida vaccine for the prevention of experimentally induced bovine pneumonic pasteurellosis. Vet Microbiol. 1989 Dec;21(2):147–154. doi: 10.1016/0378-1135(89)90027-8. [DOI] [PubMed] [Google Scholar]
  4. Clinkenbeard K. D., Mosier D. A., Confer A. W. Effects of Pasteurella haemolytica leukotoxin on isolated bovine neutrophils. Toxicon. 1989;27(7):797–804. doi: 10.1016/0041-0101(89)90047-0. [DOI] [PubMed] [Google Scholar]
  5. Confer A. W., Panciera R. J., Mosier D. A. Bovine pneumonic pasteurellosis: immunity to Pasteurella haemolytica. J Am Vet Med Assoc. 1988 Nov 15;193(10):1308–1316. [PubMed] [Google Scholar]
  6. Good M. F., Pombo D., Lunde M. N., Maloy W. L., Halenbeck R., Koths K., Miller L. H., Berzofsky J. A. Recombinant human IL-2 overcomes genetic nonresponsiveness to malaria sporozoite peptides. Correlation of effect with biologic activity of IL-2. J Immunol. 1988 Aug 1;141(3):972–977. [PubMed] [Google Scholar]
  7. Heath A. W., Playfair J. H. Conjugation of interferon-gamma to antigen enhances its adjuvanticity. Immunology. 1990 Nov;71(3):454–456. [PMC free article] [PubMed] [Google Scholar]
  8. Hughes H. P., Campos M., Godson D. L., Van Drunen Littel-Van den Hurk S., McDougall L., Rapin N., Zamb T., Babiuk L. A. Immunopotentiation of bovine herpes virus subunit vaccination by interleukin-2. Immunology. 1991 Nov;74(3):461–466. [PMC free article] [PubMed] [Google Scholar]
  9. Hughes H. P., Thomas K. R., Speer C. A. Antigen-specific lymphocyte transformation induced by oocyst antigens of Eimeria bovis. Infect Immun. 1988 Jun;56(6):1518–1525. doi: 10.1128/iai.56.6.1518-1525.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Julius M. H., Simpson E., Herzenberg L. A. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol. 1973 Oct;3(10):645–649. doi: 10.1002/eji.1830031011. [DOI] [PubMed] [Google Scholar]
  11. Kawamura H., Rosenberg S. A., Berzofsky J. A. Immunization with antigen and interleukin 2 in vivo overcomes Ir gene low responsiveness. J Exp Med. 1985 Jul 1;162(1):381–386. doi: 10.1084/jem.162.1.381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Mosier D. A., Simons K. R., Confer A. W., Panciera R. J., Clinkenbeard K. D. Serum IgG and IgM antibody response in cattle to antigens of Pasteurella haemolytica. Vet Immunol Immunopathol. 1989 Aug;22(1):53–65. doi: 10.1016/0165-2427(89)90163-3. [DOI] [PubMed] [Google Scholar]
  13. Murray H. W. Effect of continuous administration of interferon-gamma in experimental visceral leishmaniasis. J Infect Dis. 1990 May;161(5):992–994. doi: 10.1093/infdis/161.5.992. [DOI] [PubMed] [Google Scholar]
  14. Nunberg J. H., Doyle M. V., York S. M., York C. J. Interleukin 2 acts as an adjuvant to increase the potency of inactivated rabies virus vaccine. Proc Natl Acad Sci U S A. 1989 Jun;86(11):4240–4243. doi: 10.1073/pnas.86.11.4240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Potter A. A., Ready K., Gilchrist J. Purification of fimbriae from Pasteurella haemolytica A-1. Microb Pathog. 1988 Apr;4(4):311–316. doi: 10.1016/0882-4010(88)90092-7. [DOI] [PubMed] [Google Scholar]
  16. Reddy D. N., Reddy P. G., Minocha H. C., Fenwick B. W., Baker P. E., Davis W. C., Blecha F. Adjuvanticity of recombinant bovine interleukin-1 beta: influence on immunity, infection, and latency in a bovine herpesvirus-1 infection. Lymphokine Res. 1990 Fall;9(3):295–307. [PubMed] [Google Scholar]
  17. Reddy P. G., Blecha F., Minocha H. C., Anderson G. A., Morrill J. L., Fedorka-Cray P. J., Baker P. E. Bovine recombinant interleukin-2 augments immunity and resistance to bovine herpesvirus infection. Vet Immunol Immunopathol. 1989 Nov 30;23(1-2):61–74. doi: 10.1016/0165-2427(89)90110-4. [DOI] [PubMed] [Google Scholar]
  18. Roberge F. G., Lorberboum-Galski H., Le Hoang P., de Smet M., Chan C. C., Fitzgerald D., Pastan I. Selective immunosuppression of activated T cells with the chimeric toxin IL-2-PE40. Inhibition of experimental autoimmune uveoretinitis. J Immunol. 1989 Dec 1;143(11):3498–3502. [PubMed] [Google Scholar]
  19. Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J Immunol. 1981 Apr;126(4):1614–1619. [PubMed] [Google Scholar]
  20. Weinberg A. D., Shaw J., Paetkau V., Bleackley R. C., Magnuson N. S., Reeves R., Magnuson J. A. Cloning of cDNA for the bovine IL-2 receptor (bovine Tac antigen). Immunology. 1988 Apr;63(4):603–610. [PMC free article] [PubMed] [Google Scholar]
  21. Weinberg A., Merigan T. C. Recombinant interleukin 2 as an adjuvant for vaccine-induced protection. Immunization of guinea pigs with herpes simplex virus subunit vaccines. J Immunol. 1988 Jan 1;140(1):294–299. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES